Prognostic value of pharmacological stress echocardiography is affected by concomitant antiischemic therapy at the time of testing

Circulation

Volumn 109, Issue 20, 2004, Pages 2428-2431

  Sicari, Rosa ^a   Cortigiani, Lauro ^a   Bigi, Riccardo ^a   Landi, Patrizia ^a   Raciti, Mauro ^a   Picano, Eugenio ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Coronary disease; Echocardiography; Ischemia; Prognosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPYRIDAMOLE; DOBUTAMINE; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STRESS ECHOCARDIOGRAPHY; SURVIVAL;

CORONARY ARTERIOSCLEROSIS; DIAGNOSTIC ERRORS; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 2542489064     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000127427.03361.5E     Document Type: Article

References (21)

1. Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Circulation. 1992;85:1604-1612.
2. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the management of Patients With Chronic Stable Angina). Circulation. 2003;107:149-158.
3. Sicari R, Pasanisi E, Venneri L, et al. Stress echo results predict mortality: a large scale multicenter prospective international study. J Am Coll Cardiol. 2003;41:589-595.
4. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: correlation with exercise echocardiography. Circulation. 1991;83:1256-1262.
5. Dodi C, Pingitore A, Sicari R, et al. Effects of antianginal therapy with calcium antagonists and nitrates on dobutamine atropine-stress echocardiography: comparison with exercise electrocardiography. Eur Heart J. 1997;18:242-247.
6. San Roman JA, Vilacosta I, Castillo JA, et al. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease: comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. Chest. 1996;110:1248-1254.
7. Ferrara N, Longobardi G, Nicolino A, et al. Protective effect of beta-blockade on dipyridamole-induced myocardial ischemia: role of heart rate. Eur Heart J. 1995;16:903-908.
8. Ferrara N, Longobardi G, Nicolino A, et al. Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. Am J Cardiol. 1992;70:724-727.
9. Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 1994;15:355-360.
10. Armstrong WF, Pellikka PA, Ryan T, et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography: Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 1998;11:97-104.
11. Picano E, Bedetti G, Varga A, et al. The comparable diagnostic accuracy of dobutamine and dipyridamole stress echocardiography: a meta analysis. Coron Artery Dis. 2000;11:151-159.
12. Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. J Am Coll Cardiol. 1999;34:1769-1777.
13. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 1979;300:1350-1358.
14. Picano E, Mathias W, Pingitore A, et al, on behalf of the: EDIC Study Group. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet. 1994;344:1190-1192.
15. Marwick TH, Nemec JJ, Pashkow FJ, et al. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81.
16. Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography. Circulation. 2001;103:2566-2571.
17. Wang TJ, Stafford RS. National patterns and predictors of beta-blocker use in patients with coronary artery disease. Arch Intern Med. 1998;158:1901-1906.
18. Freemantle N, Cleland J, Young P, et al. Beta-blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730-1737.
19. Phillips KA, Shlipak MG, Coxson, et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA. 2000;284:2748-2754.
20. Picano E. Stress echocardiography: a historical perspective. Am J Med. 2003;114:126-130.
21. Picano E. Prognosis. In: Picano E, ed. Stress Echocardiography. 4th ed. Berlin, Germany: Springer Verlag; 2003.